Impaired_binding_properties_of_thyroxine-binding_globulin_in_hepatocellular_carcinoma_and_chronic_liver_disease._To_determine_the_factors_underlying_the_apparent_reduction_in_binding_ability_of_thyroxine-binding_globulin_in_hepatocellular_carcinoma,_hormone-binding_characteristics_were_further_examined_in_patients_with_this_disease_and_in_control_subjects._No_differences_in_affinity_constants_with_respect_to_triodothyronine_or_serum_thyroxine-binding_globulin_from_hepatocellular_carcinoma,_cirrhotic_and_normal_subjects_were_found._The_affinity_for_thyroxine_was_significantly_reduced_in_hepatocellular_carcinoma_(0.41_+/-_0.13_x_10(10)_mol-1)_and_cirrhotic_(0.65_+/-_0.1_x_10(10)_mol-1)_patients_compared_with_normal_subjects_(0.94_+/-_0.7_x_10(10)_mol-1)._Investigations_carried_out_on_liver_tissue_obtained_from_patients_with_hepatocellular_carcinoma_and_chronic_liver_disease_showed_that_thyroxine-binding_globulin_within_tumor_tissue_was_elevated_and_bound_less_exogenous_tracer_hormone_compared_with_that_obtained_from_nontumor_tissue._Tumor-derived_thyroxine-binding_globulin_with_altered_binding_properties_is,_at_least_partly,_responsible_for_the_abnormal_behavior_of_the_serum_protein_in_patients_with_hepatocellular_carcinoma.